Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury.

Murohara, T; Margiotta, J; Phillips, L M; Paulson, J C; DeFrees, S; Zalipsky, S; Guo, L S; Lefer, A M

Murohara, T; Margiotta, J; Phillips, L M; Paulson, J C; DeFrees, S; Zalipsky, S; Guo, L S; Lefer, A M.

Affiliation

Murohara T; Department of Physiology, Thomas Jefferson University, Philadelphia, PA 19107, USA.

Cardiovasc Res ; 30(6): 965-74, 1995 Dec.

Article in En | MEDLINE | ID: mdl-8746213

Subject(s)

Myocardial Ischemia/drug therapy; Myocardial Reperfusion Injury/prevention & control; Oligosaccharides/administration & dosage; Acetylcholine/pharmacology; Animals; Calcimycin/pharmacology; Cats; Cell Adhesion/drug effects; Creatine Kinase/blood; Drug Carriers; Endothelium, Vascular/drug effects; In Vitro Techniques; Liposomes; Male; Myocardial Ischemia/enzymology; Myocardial Reperfusion Injury/enzymology; Myocardium/enzymology; Neutrophils/physiology; Peroxidase/metabolism; Sialyl Lewis X Antigen; Thrombin/pharmacology; Vasodilation/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Oligosaccharides / Myocardial Reperfusion Injury / Myocardial Ischemia Limits: Animals Language: En Journal: Cardiovasc Res Year: 1995 Document type: Article Affiliation country: United States Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links